{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:02Z","timestamp":1791348602295,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011539","name":"University of Minnesota Masonic Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019888","name":"College of Pharmacy, University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD036254"],"award-info":[{"award-number":["S10 OD036254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA030199"],"award-info":[{"award-number":["P30 CA030199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104480","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:53:33Z","timestamp":1787327613000},"page":"104480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-throughput chemical screening identifies Venetoclax as an enhancer of extracellular vesicle\u2013mediated nanoparticle transport into solid tumors"],"prefix":"10.1016","volume":"115","author":[{"given":"Yiqin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104480_bib0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.xphs.2026.104480_bib0002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104480_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104480_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2026.104480_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.xphs.2026.104480_bib0006","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat Mater"},{"issue":"5","key":"10.1016\/j.xphs.2026.104480_bib0007","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer","volume":"127","author":"Liu","year":"2017","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.xphs.2026.104480_bib0008","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.nanolett.9b03211","article-title":"Transcytosis of nanomedicine for tumor penetration","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.xphs.2026.104480_bib0009","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.xphs.2026.104480_bib0010","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/smll.201100001","article-title":"Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials","volume":"7","author":"Zhao","year":"2011","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.xphs.2026.104480_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102441","article-title":"Extracellular vesicles mediate the intercellular exchange of nanoparticles","volume":"9","author":"Wu","year":"2022","journal-title":"Adv Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104480_bib0012","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nmat3982","article-title":"Etchable plasmonic nanoparticle probes to image and quantify cellular internalization","volume":"13","author":"Braun","year":"2014","journal-title":"Nat Mater"},{"issue":"4","key":"10.1016\/j.xphs.2026.104480_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104480_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202200173","article-title":"Identification of an ALK-2 inhibitor as an agonist for intercellular exchange and tumor delivery of nanomaterial","volume":"6","author":"Wu","year":"2023","journal-title":"Adv Therapeut"},{"issue":"3","key":"10.1016\/j.xphs.2026.104480_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact of high-throughput screening in biomedical research","volume":"10","author":"Macarron","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.xphs.2026.104480_bib0016","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nchembio.2007.17","article-title":"High-throughput screening assays for the identification of chemical probes","volume":"3","author":"Inglese","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104480_bib0017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev Technol"},{"issue":"12","key":"10.1016\/j.xphs.2026.104480_bib0018","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","article-title":"From 3D cell culture to organs-on-chips","volume":"21","author":"Huh","year":"2011","journal-title":"Trends Cell Biol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104480_bib0019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","article-title":"nab-Paclitaxel mechanisms of action and delivery","volume":"170","author":"Yardley","year":"2013","journal-title":"J Control Release"},{"issue":"31","key":"10.1016\/j.xphs.2026.104480_bib0020","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil\u2013based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104480_bib0021","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.xphs.2026.104480_bib0022","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1816641","article-title":"Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration","volume":"9","author":"Welsh","year":"2020","journal-title":"J Extracell Vesicl"},{"issue":"4","key":"10.1016\/j.xphs.2026.104480_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1358\/dot.2016.52.4.2470954","article-title":"Venetoclax: bcl-2 inhibition for the treatment of chronic lymphocytic leukemia","volume":"52","author":"Del Poeta","year":"1998","journal-title":"Drugs Today"},{"key":"10.1016\/j.xphs.2026.104480_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2020.00090","article-title":"Extracellular vesicles and chemotherapy resistance in the AML microenvironment","volume":"10","author":"Nehrbas","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104480_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55231-9","article-title":"Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia","volume":"15","author":"Forte","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.xphs.2026.104480_bib0026","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","article-title":"Context-specific regulation of extracellular vesicle biogenesis and cargo selection","volume":"24","author":"Dixson","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15","key":"10.1016\/j.xphs.2026.104480_bib0027","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.215210","article-title":"The interplay between exosomes and autophagy\u2013partners in crime","volume":"131","author":"Xu","year":"2018","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104480_bib0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc.2015.17","article-title":"Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies","volume":"16","author":"Delbridge","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2026.104480_bib0029","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicl"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:29Z","timestamp":1791345269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003308"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104480","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput chemical screening identifies Venetoclax as an enhancer of extracellular vesicle\u2013mediated nanoparticle transport into solid tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104480"}}